NCT04374877 2025-11-10
Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors
Coherus Oncology, Inc.
Phase 1 Completed
Coherus Oncology, Inc.
TopAlliance Biosciences
BGI, China
Tianjin Medical University Cancer Institute and Hospital